Strategy for intention to treat analysis in randomised trials with missing outcome data
暂无分享,去创建一个
Ian R White | James Carpenter | Stuart J Pocock | I. White | J. Carpenter | S. Pocock | N. Horton | Nicholas J Horton | reader in medical and social statistics
[1] M. Kenward,et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.
[2] Sally Hollis,et al. A graphical sensitivity analysis for clinical trials with non‐ignorable missing binary outcome , 2002, Statistics in medicine.
[3] Robert O'Neill,et al. MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets , 2009, Journal of biopharmaceutical statistics.
[4] V. Agrawal,et al. Authors’ reply , 2010, Indian journal of psychiatry.
[5] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[6] J. Ioannidis,et al. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement , 2011, European Journal of Epidemiology.
[7] I. White,et al. Eliciting and using expert opinions about dropout bias in randomized controlled trials , 2007, Clinical trials.
[8] A. Astrup,et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2009, The Lancet.
[9] A. Mackinnon. Statistical treatment of withdrawal in trials of anti-dementia drugs , 2008, The Lancet.
[10] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[11] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.
[12] Michael G. Kenward,et al. Missing Data in Clinical Trials - A Practical Guide , 2007 .
[13] W. Shih,et al. Current Controlled Trials in Cardiovascular Medicine , 2002 .
[14] Douglas G Altman,et al. Missing outcomes in randomized trials: addressing the dilemma , 2009, Open medicine : a peer-reviewed, independent, open-access journal.
[15] Hideaki Watanabe,et al. Points to Consider on Missing Data , 2006 .
[16] P Peduzzi,et al. Analysis as-randomized and the problem of non-adherence: an example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass Surgery. , 1993, Statistics in medicine.
[17] Mary Sano,et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study , 2008, The Lancet.
[18] Zhang Jing,et al. Guideline on missing data in confirmatory clinical trials , 2012 .
[19] J. Ware,et al. Interpreting incomplete data in studies of diet and weight loss. , 2003, The New England journal of medicine.
[20] J. Wittes. Missing Inaction: Preventing Missing Outcome Data in Randomized Clinical Trials , 2009, Journal of biopharmaceutical statistics.